Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TAP, SB Pressed By Rep. Bliley To Provide More Drug Pricing Documents

Executive Summary

House Commerce Committee Chairman Tom Bliley (R-Va.) is requesting that TAP Pharmaceutical and SmithKline Beecham turn over additional documents to help the committee in its investigation of reimbursement for drugs covered by Medicare.

You may also be interested in...



GSK Remains Positive On Medicare Rx, Outcome Of AWP Suit

GlaxoSmithKline continues to see only an upside from the potential creation of a Medicare prescription drug benefit, Pharmaceutical Operations President David Stout told investors in New York City Feb. 13

GSK Remains Positive On Medicare Rx, Outcome Of AWP Suit

GlaxoSmithKline continues to see only an upside from the potential creation of a Medicare prescription drug benefit, Pharmaceutical Operations President David Stout told investors in New York City Feb. 13

Bayer Drug Prices To Be Monitored By HHS Under Medicaid Fraud Settlement

Bayer will provide states and the federal government with the average selling prices of its drugs to help them set reasonable reimbursement rates under a tentative settlement agreement with the Justice Department.

Related Content

UsernamePublicRestriction

Register

ID005817

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel